Trial Search Results
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the body) in prostate tissue that has been removed during prostatectomy, as well as in the blood.
Stanford is currently not accepting patients for this trial.
National Center for Complementary and Integrative Health (NCCIH)
- Drug: Soy Isoflavone Nutritional Supplements
- Scheduled for prostatectomy
- Willing and able to consume study tablets for at least 2 weeks prior to surgery
- Willing to accept random assignment
- Signed informed consent
- Unwilling to avoid soy intake during the study period
- Currently taking antibiotics
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study